Advertisement
Advertisement

NXTC

NXTC logo

NextCure, Inc. Common Stock

9.76
USD
Sponsored
-0.42
-4.13%
May 08, 15:59 UTC -4
Closed
exchange

After-Market

9.88

+0.13
+1.28%

NextCure, Inc. Common Stock Profile

About

NextCure Inc. is a clinical-stage biopharmaceutical company. It is engaged in discovering and developing immunomedicines to treat cancer and other immune-related diseases. The company's product candidate consists of NC318 and NC410 which are in clinical stage. NextCure Inc. is based in Beltsville, Maryland.

Info & Links

CEO

Michael Richman

Headquarters

9000 VIRGINIA MANOR ROAD, SUITE 200
BELTSVILLE, MD 20705, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.nextcure.com

Auditor

Ernst & Young LLP

Share holders

16

Employees

40

NextCure, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

35.66M

Enterprise Value

20.49M

Enterprise Value/EBITDA(ttm)

-0.38

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.12

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-152.90%

Return on Invested Capital(ttm)

-167.84%

Return on Assets(ttm)

-109.17%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-54.59M

Net Income Available to Common(ttm)

-54.66M

Diluted EPS(ttm)

-20.00

Share Statistics

Beta (5Y Monthly)

1.57

52-Week Change

111.26%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

3.61M

Dividend Yield

0.00%

Float4

2.92M

% Held by Insiders

17.90%

% Held by Institutions

42.65%

Balance Sheet

Total Cash(mrq)

29.74M

Total Cash Per Share(mrq)

8.23

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

4.14%

Quick Ratio(mrq)

4.14%

Book Value Per Share(mrq)

9.97

Cash Flow

Operating Cash Flow Per Share(ytd)

-17.45

Free Cash Flow(ytd)

-49.61M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement